The treatments that we develop can greatly impact the lives of patients with CNS conditions. As such, we believe all patients should have access to them – regardless of financial condition or ability to pay.
When appropriate and permitted by law, we also make our investigational treatments available through our clinical trials. For more information on access to investigational medicines, please visit https://www.clinicaltrials.gov.
Please read below for more information on Avanir’s Patient Assistance programs.
(dextromethorphan HBr and quinidine sulfate) capsules 20 mg / 10 mg
Medicare Part D Patients: Patient Services, Inc. offers co-pay assistance for those on Medicare Part D who cannot afford the out-of-pocket costs. To determine if you qualify, click here.
Patients without Insurance: If you have no insurance, and need assistance, please click here.
For more information on Avanir patient assistance programs, please visit the NUEDEXTA website.